Tuberculosis-Associated Hemophagocytic Lymphohistiocytosis: Diagnostic Challenges and Determinants of Outcome
Open Forum Infectious Diseases · 28.03.2024 · 11 (4)
DOI: 10.1093/ofid/ofad697 ↗Kurz gefasst
Fachartikel in der Zeitschrift Open Forum Infectious Diseases, online erschienen am 11.01.2024. Verfasst von Lisa Kurver und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, the Netherlands. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: UCLH NIHR, Biomedical Research Centre, clinical fellowship of The Netherlands Organization.
Abstract (Originalsprache)
Background
Tuberculosis (TB) can induce secondary hemophagocytic lymphohistiocytosis (HLH), a severe inflammatory syndrome with high mortality. We integrated all published reports of adult HIV-negative TB-associated HLH (TB-HLH) to define clinical characteristics, diagnostic strategies, and therapeutic approaches associated with improved survival.
Methods
PubMed, Embase, and Global Index Medicus were searched for eligible records. TB-HLH cases were categorized into (1) patients with a confirmed TB diagnosis receiving antituberculosis treatment while developing HLH and (2) patients presenting with HLH of unknown cause later diagnosed with TB. We used a logistic regression model to define clinical and diagnostic parameters associated with survival.
Results
We identified 115 individual cases, 45 (39.1%) from countries with low TB incidence (<10/100 000 per year). When compared with patients with HLH and known TB (n = 21), patients with HLH of unknown cause (n = 94) more often had extrapulmonary TB (66.7% vs 88.3%), while the opposite was true for pulmonary disease (91.5% vs 59.6%). Overall, Mycobacterium tuberculosis was identified in the bone marrow in 78.4% of patients for whom examination was reported (n = 74). Only 10.5% (4/38) of patients tested had a positive result upon a tuberculin skin test or interferon-γ release assay. In-hospital mortality was 28.1% (27/96) in those treated for TB and 100% (18/18) in those who did not receive antituberculosis treatment (P < .001).
Conclusions
Tuberculosis should be considered a cause of unexplained HLH. TB-HLH is likely underreported, and the diagnostic workup of patients with HLH should include bone marrow investigations for evidence of Mycobacerium tuberculosis. Prompt initiation of antituberculosis treatment likely improves survival in TB-HLH.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, the Netherlands.
- The Hospital for Tropical Diseases, University College London Hospitals NHS Foundation Trust, London, UK.
- Department of Hematology, Radboud University Medical Center, Nijmegen, the Netherlands.
- Division of Infection and Immunity, University College London, London, UK.
ORCID-Profile: Lisa Kurver, Timothy Seers, Suzanne van Dorp, Reinout van Crevel, Gabriele Pollara, Arjan van Laarhoven
Förderung
- UCLH NIHR
- Biomedical Research Centre
- clinical fellowship of The Netherlands Organization
- Health Research and Development
Zitieren
APA
Kurver, L., Seers, T., van Dorp, S., van Crevel, R., Pollara, G., & van Laarhoven, A. (2024). Tuberculosis-Associated Hemophagocytic Lymphohistiocytosis: Diagnostic Challenges and Determinants of Outcome. Open Forum Infectious Diseases, 11(4). https://doi.org/10.1093/ofid/ofad697
Vancouver
Kurver L, Seers T, van Dorp S, van Crevel R, Pollara G, van Laarhoven A. Tuberculosis-Associated Hemophagocytic Lymphohistiocytosis: Diagnostic Challenges and Determinants of Outcome. Open Forum Infectious Diseases. 2024;11(4). doi:10.1093/ofid/ofad697
BibTeX
@article{Kurver2024,
author = {Kurver, Lisa and Seers, Timothy and van Dorp, Suzanne and van Crevel, Reinout and Pollara, Gabriele and van Laarhoven, Arjan},
title = {Tuberculosis-Associated Hemophagocytic Lymphohistiocytosis: Diagnostic Challenges and Determinants of Outcome},
journal = {Open Forum Infectious Diseases},
year = {2024},
volume = {11},
number = {4},
doi = {10.1093/ofid/ofad697}
}
EUVIMED